Pimnipa Jieraviriyapun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Pimnipa Jieraviriyapun has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Witaya Suriyasathaporn
School of Veterinary Medicine, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50100, Thailand
2 shared publications - Areerat Chuasakhonwilai
Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50100, Thailand
1 shared publication - Duanghathai Saipinta
School of Veterinary Medicine, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50100, Thailand
1 shared publication - Kanawee Warrit
Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50100, Thailand
1 shared publication - Kittidaj Tanongpitchayes
Faculty of Veterinary Science, Prince of Songkhla University, Songkhla 90110, Thailand
1 shared publication - Luddawon Somrup
Northern Regional Veterinary Healthcare and Learning Center, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50100, Thailand
1 shared publication
Latest Publications
- Open Access
- 8 October 2026
- Published by MDPI AG in Veterinary Sciences
- Vol. 13 (10) , 1054
In Vitro Antimicrobial Activity of Chlorhexidine–Curcumin Nanoformulations for Teat Dipping Against Mastitis Pathogens
Bovine mastitis is a major problem affecting dairy production, and teat disinfection is important for reducing the risk of bacterial infection. Curcumin has antimicrobial properties, but its poor water solubility limits its use in aqueous formulations. This study aimed to develop chlorhexidine–curcumin nanoformulations (CCNs) and perform preliminary in vitro screening of these nanoformulations as candidate teat-dipping formulations. Four CCNs containing increasing concentrations of curcumin (0%, 0.1%, 0.5%, and 0.9% w/v; CCN0, CCN0.1, CCN0.5, and CCN0.9, respectively) were prepared. CCN0, CCN0.1, and CCN0.5 were formulated as oil-in-water nanoemulsions, whereas CCN0.9 was prepared as a curcumin-β-cyclodextrin inclusion complex. The physicochemical properties were characterized, and the antibacterial activity was evaluated in vitro by agar well diffusion against six mastitis-associated pathogens. CCN0.9 showed the largest inhibition zones overall (20.07 ± 1.05–28.85 ± 1.05 mm; p < 0.05), while CCN0.1 and CCN0.5 showed activity comparable to or greater than that of commercial teat dips against several pathogens. CCN0.5 showed the most favorable nanoemulsion characteristics, with a particle size of 94.77 nm and a zeta potential of −46.57 mV. Overall, CCNs demonstrated antibacterial activity against mastitis pathogens, supporting their potential as candidate teat-dip formulations. Further teat irritation and in vivo efficacy studies are needed before field application.
- 8 October 2026
- Published by MDPI AG in Veterinary Sciences
- Vol. 13 (10) , 1054
Open AccessIn Vitro Antimicrobial Activity of Chlorhexidine–Curcumin Nanoformulations for Teat Dipping Against Mastitis Pathogens
Bovine mastitis is a major problem affecting dairy production, and teat disinfection is important for reducing the risk of bacterial infection. Curcumin has antimicrobial properties, but its poor water solubility limits its use in aqueous formulations. This study aimed to develop chlorhexidine–curcumin nanoformulations (CCNs) and perform preliminary in vitro screening of these nanoformulations as candidate teat-dipping formulations. Four CCNs containing increasing concentrations of curcumin (0%, 0.1%, 0.5%, and 0.9% w/v; CCN0, CCN0.1, CCN0.5, and CCN0.9, respectively) were prepared. CCN0, CCN0.1, and CCN0.5 were formulated as oil-in-water nanoemulsions, whereas CCN0.9 was prepared as a curcumin-β-cyclodextrin inclusion complex. The physicochemical properties were characterized, and the antibacterial activity was evaluated in vitro by agar well diffusion against six mastitis-associated pathogens. CCN0.9 showed the largest inhibition zones overall (20.07 ± 1.05–28.85 ± 1.05 mm; p < 0.05), while CCN0.1 and CCN0.5 showed activity comparable to or greater than that of commercial teat dips against several pathogens. CCN0.5 showed the most favorable nanoemulsion characteristics, with a particle size of 94.77 nm and a zeta potential of −46.57 mV. Overall, CCNs demonstrated antibacterial activity against mastitis pathogens, supporting their potential as candidate teat-dip formulations. Further teat irritation and in vivo efficacy studies are needed before field application.
- Open Access
Effects of Advanced Platelet-Rich Fibrin on Bone Healing in the Treatment of Canine Appendicular Fractures
Although internal fixation and surgical approaches promote fracture healing, some outcomes remain unsatisfactory. Advanced platelet-rich fibrin (A-PRF) has been shown to provide more growth factors, and in vitro cell proliferation has not been evaluated for treating bone fractures in veterinary medicine. The purpose of this study was to evaluate the bone-healing activity of A-PRF in traumatic canine fractures. Twelve dogs with single radius–ulna or tibia–fibula fractures were randomly assigned to two groups: a control group and an A-PRF group. Both groups were treated with a locking compression plate and screws and received pain control. Post-operatively, dogs were evaluated for serum C-reactive protein (CRP) levels and post-operative pain scores on days 1, 3, and 7. Lameness and weight-bearing scores were evaluated on days 1, 3, 7, 14, 30, and 60. Bone healing was assessed at 2 weeks, 1 month, and 2 months using calculated relative bone density (%). Compared with the control, the A-PRF group showed higher bone density at 2 months and lower lameness at 14 days post-operatively. Although the CRP level, an inflammation response marker, was higher in the A-PRF group within one day. No significant difference in pain score was observed. In conclusion, A-PRF serves as an effective adjunctive therapy for promoting bone healing when treating canine appendicular fractures with surgical internal fixation.
Open AccessEffects of Advanced Platelet-Rich Fibrin on Bone Healing in the Treatment of Canine Appendicular Fractures
Although internal fixation and surgical approaches promote fracture healing, some outcomes remain unsatisfactory. Advanced platelet-rich fibrin (A-PRF) has been shown to provide more growth factors, and in vitro cell proliferation has not been evaluated for treating bone fractures in veterinary medicine. The purpose of this study was to evaluate the bone-healing activity of A-PRF in traumatic canine fractures. Twelve dogs with single radius–ulna or tibia–fibula fractures were randomly assigned to two groups: a control group and an A-PRF group. Both groups were treated with a locking compression plate and screws and received pain control. Post-operatively, dogs were evaluated for serum C-reactive protein (CRP) levels and post-operative pain scores on days 1, 3, and 7. Lameness and weight-bearing scores were evaluated on days 1, 3, 7, 14, 30, and 60. Bone healing was assessed at 2 weeks, 1 month, and 2 months using calculated relative bone density (%). Compared with the control, the A-PRF group showed higher bone density at 2 months and lower lameness at 14 days post-operatively. Although the CRP level, an inflammation response marker, was higher in the A-PRF group within one day. No significant difference in pain score was observed. In conclusion, A-PRF serves as an effective adjunctive therapy for promoting bone healing when treating canine appendicular fractures with surgical internal fixation.